5 d. ago Osisko Development Intercepts 57.29 g/t Gold Over 3.05 Meters, 625.95 g/t Gold Over 0.5 Meters and 15.26 g/t Gold Over 4.4 Meters in Lowhee Infill Drilling at Cariboo Gold Project

MONTREAL, Sept. 08, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce results from its infill and exploration diamond drill, and development sampling campaigns in the Lowhee Zone within the Company’s permitted, 100%-owned Cariboo Gold Project (“Cariboo” or the “Project“), located in central British […]

Sport

6 d. ago Opus One Gold Corp Noyell Gold Project, Zone 1 Discovery, Company Update

NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Sept. 08, 2025 (GLOBE NEWSWIRE) — Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to present a technical update after a successful drilling program carried out at the beginning of winter 2025 on its 100% owned […]

Economics

9 d. ago Critical One Acquires KCR Project – Historic Drill Hole Intersected Visible Gold Assaying 64.1 g/t Gold Within 20.4 Metre Interval Grading 3.54 g/t Gold

TORONTO, Sept. 04, 2025 (GLOBE NEWSWIRE) — Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce the acquisition of the KCR Gold Project (“KCR Project”) including the Slam Gold Zone discovery (Figure 1) contiguous to the Company’s extensive land holdings at […]

Events

1 week ago Rakovina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that Executive Chairman, Jeffrey Bacha, and Chief Financial Officer, Dr. David Kideckel, will attend and present at the H.C. Wainwright 27th Annual Global […]

Culture

1 week ago ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol […]

Other

2 w. ago Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to seven new non-officer employees consisting of an aggregate of 55,300 share options. All of the […]

Other

2 w. ago ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation

Manufacturing of validated dengue epitope underway; proprietary immunization studies in rabbit model to assess monoclonal antibody (mAb) responses. AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery today announced the next milestone in its universal dengue vaccine program. Building on its […]

Sport

2 w. ago Junshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate Updates

SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2025 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2025, the total revenue of Junshi […]

Other

2 w. ago Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis

VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that Chief Scientific Officer Dr. Mads Daugaard has been invited to present this week at the 13th Tuscany Retreat on Cancer Research and […]

Events